HOLD - Maintain position, monitor next earnings print for estimate revision confirmation, wait for technical triggers (reversal above 122.35 with momentum confirmation or breakdown below 118.86 on heavy volume)

• 200 SMA still rising: 121.5 in mid-July to 122.35 today - long-term uptrend intact
• MACD histogram at +0.03 shows decelerating decline, not a sell signal - MACD line at negative 0.90 vs signal at negative 0.93
• RSI at 43 is well above oversold territory
• ATR compressed at 1.87
• Price at lower Bollinger band - at support, not in free fall
• Interest expense climbed 50% over three years - but this is sector-wide, not unique to DUK
• OCF covers approximately 70% of total cash needs - sector structure, not thesis-breaking
• DUK rolling $5 billion-plus in debt annually at higher rates
• 3.64% yield gives ~136 basis points pickup over Treasuries for non-high-bracket investors
• Dividend Aristocrat with annual increases through prior rate cycles including 2022-2023
• Dividend coverage of 3.7x from operating cash flow
• Normalized EBITDA growth of 32% over three years
• ROE near authorized return
• 7.3% drawdown over six weeks is normal utility volatility - DUK has done this multiple times in last three years
• 52-week low at 113.90 - probability distribution suggests sideways chop with bounce possibility, not straight down
• One quarter of negative estimate revisions post-Q2 - no confirmed trend, waiting for Q3
• AI data center thesis is slow structural tailwind for regulated rate base growth over next decade
• Vistra 19% drawdown irrelevant to DUK - VST is speculative hot-money, DUK is defensive
• Lower Bollinger band with compressed bands suggests coiled compression pattern - probability favors bounce at support

→ vs aggressive: Selling 25-50% of position based on 6-week pullback is performance anxiety dressed as conviction, not risk management - discipline means holding thesis through normal volatility and only acting when thesis materially changes

→ vs aggressive: 200 SMA rolling over in 2-4 weeks is speculation, not analysis - 200 SMA could continue grinding higher while price chops below it in consolidation phase

→ vs aggressive: MACD histogram +0.03 is not a 'fake positive divergence that traps buyers' - it means rate of decline is decelerating, early stage of potential momentum bottom

→ vs aggressive: Framing DUK as bond substitution trade ignores its role as defensive ballast, dividend growth, and lower portfolio beta in multi-asset portfolios

→ vs aggressive: Interest expense and leverage metrics are sector-wide, not DUK-specific - selling DUK on these metrics means selling every regulated utility, and doesn't escape sector headwind

→ vs aggressive: Estimate revisions are one-quarter data point - proper response is to monitor, not act; need Q3 confirmation before trimming

→ vs aggressive: AI/data center thesis supports HOLD, not SELL - slow structural tailwind is precisely what justifies holding defensive utility for rate base growth over next decade

→ vs aggressive: Vistra 19% drawdown is irrelevant to DUK analysis - VST is speculative IPP space, DUK is regulated contracted defensive name; VST falling doesn't indicate anything about DUK's Carolinas data center load

→ vs aggressive: 7.3% drawdown is not a 'structural tell' - utilities routinely pull back 5-10% in any given year as rate expectations shift

→ vs aggressive: 52-week low at 113.90 as price target is 'directional bet masquerading as analysis' - with compressed ATR and Bollinger bands at lower band, probability distribution favors sideways chop with bounce possibility, not straight down

→ vs aggressive: Selling at support zone forces buy-back decision later at higher price with worse risk-reward - whipsaw transactions destroy returns over time

HOLD with 10-20% position trim at better technical levels; preserve majority of position to maintain structural thesis exposure; trim at relief bounce toward 124.55 upper Bollinger band or 50 SMA at 123.74, or on confirmed breakdown below 118.86 on heavy volume

• 200 SMA rising from 121.5 to 122.35 over past couple months - long-term uptrend still intact and grinding higher
• ATR compressed at 1.87 with Bollinger bands squeezed - probability distribution suggests chop with potential relief bounce rather than clean waterfall to 52-week low
• Analyst estimate revisions post-Q2 EPS beat represent aggregated forward view of sell-side analysts with access to company guidance and channel checks - not random noise to dismiss
• Dividend Aristocrat status is backward-looking credential, not forward-looking catalyst; balance sheet under real pressure from compounding interest expense
• Vistra 19 percent drawdown does not invalidate DUK AI utility thesis - VST is speculative IPP with commodity-linked power prices and ERCOT exposure versus DUK's regulated monopoly with state-level rate base growth
• Aggressive analyst's projection that 200 SMA will roll over in 2-4 weeks is directional bet, not analysis; 'straight line down to 113.90' framing creates whipsaw risk
• Conservative analyst's 'one quarter of data' dismissal of estimate revisions is intellectual comfort food - estimate revisions are not random noise
• 10-20% trim accomplishes three things: reduces concentration risk in macro-sensitive name, locks in accrued dividend yield, preserves dry powder for re-entry or reallocation
• Re-entry criteria: price reclaims 200 SMA at 122.35 with RSI back above 50 and bullish MACD crossover confirmed
• Diversification consideration: selling DUK to buy another regulated utility does not de-risk - consider less rate-sensitive defensive names or cash for optionality
• Appropriate time horizon is multi-month position management driven by rate case outcomes and capex deployment, not tactical swing trading with stop loss at 124.55

→ vs aggressive: Projection that 200 SMA will roll over in 2-4 weeks is directional bet not analysis; treating Vistra 19% drawdown as evidence against AI utility thesis is intellectually dishonest since VST is speculative IPP versus regulated monopoly; 'straight line down to 113.90' framing creates whipsaw risk when ATR is compressed at 1.87 and Bollinger bands are squeezed

→ vs conservative: Dismissing analyst estimate revisions as 'one quarter of data' and arguing 'monitor not act' is delaying decision until deterioration is already priced in - estimate revisions represent aggregated forward view of sell-side analysts with access to company guidance; overplaying dividend Aristocrat narrative ignores real balance sheet pressure from compounding interest expense